Journals / Journal of Clinical and Experimental Investigations / 2013 / Cilt: 4 - Sayı: 4

Seropositivity of HBsAg, anti-HCV and anti-HIV in preoperative patients

Preoperatif hastalarda HBsAg, anti-HCV ve anti-HIV seropozitifliği

Pages
449–452
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, all patients should be considered as potential carriers regarded as a carrier of the potential for infection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The infections caused by human immunodefi- ciency virus (HIV), hepatitis B (HBV) and C (HCV) viruses pose a serious occupational risk for the healthcare work- ers especially those in emergency services, laboratories and surgery wards.
📊
Key Findings & Data:Addi- tionally, serological screening of the preoperative patients could decrease the risk for exposure.
💡
Conclusion & Impact:In addition, all patients should be considered as potential carriers regarded as a carrier of the potential for infection.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The infections caused by human immunodefi- ciency virus (HIV), hepatitis B (HBV) and C (HCV) viruses pose a serious occupational risk for the healthcare work- ers especially those in emergency services, laboratories and surgery wards. Vaccination and establishment of the strict biosafety procedures are the main principles to pre- vent blood-borne infections in healthcare workers. Addi- tionally, serological screening of the preoperative patients could decrease the risk for exposure. In this study, we aimed to determine the seroprevalence of HBsAg, anti- HCV, anti-HIV 1/2 in preoperative patients. Methods: Hospital automation records were evaluated retrospectively for 4.367 patients who were scheduled for surgery and scanned for anti-HIV 1/2, HBsAg and anti- HCV as preoperative procedures in the preparation period of operation between January 2012 and December 2012. Results: HBsAg positivity rate was found in 7.7% (n=336), anti-HCV positivity rate was found in 2.3% (n=101). A two (0.05%) of five patients were positive for anti-HIV 1/2 was found positive verification test and the other three samples were accepted as false positive test results. Conclusion: All healthcare workers must be trained about occupational diseases and vaccinated against Hepatitis B. Universal precautions must be strictly followed particu- larly in the operating room. In addition, all patients should be considered as potential carriers regarded as a carrier of the potential for infection.

Özet

Amaç: Kan yolu ile bulaşan insan immün yetmezlik virü-sü (HIV), hepatit B ve C virüs enfeksiyonları sağlık çalı- şanları için özellikle acil servis, laboratuvarlar ve cerrahi servislerde ciddi bir mesleki risk oluşturmaktadır. Sağlık çalışanları için aşılama ve sıkı biyogüvenlik önlemlerinin alınması kan kaynaklı enfeksiyonlardan korunmada temelilkedir. Ayrıca cerrahi girişim öncesi hastaların serolojiktarama testleri bulaş riskini azaltır. Bu çalışmada, preope- ratif hastalardaki HBsAg, anti-HCV, anti-HIV 1/2 seropre- valansını belirlemek amaçlanmıştır.Yöntemler: Ocak 2012-Aralık 2012 tarihleri arasında ameliyat hazırlığı döneminde preoperatif işlemler olarak HBsAg, anti-HCV, anti-HIV 1/2 araştırılan 4,367 hastanın kan örneği sonuçları geriye dönük olarak değerlendirildi. Bulgular: HBsAg pozitiflik oranı %7,7 (n=336), anti-HCV pozitiflik oranı %2,3 (n=101) olarak belirlenmiştir. Anti-HIV 1/2 pozitif saptanan 5 hastanın 2’si (%0.05) doğrulama testiyle pozitif saptanmış, doğrulama testi negatif 3 hasta yalancı pozitif olarak kabul edilmiştir. Sonuç: Kan ve vücut sıvılarıyla bulaşan hastalıklar hakkında tüm sağlık çalışanları eğitilmeli, HBV’ye karşı aşılanmalı, ameliyathanelerde enfeksiyon gelişimini engelleyecek evrensel önlemlerle ilgili standartlar ciddiyetle uygulanmalı ve temas edilen her hastanın enfekte olabi- leceği kabul edilmelidir.

🔖

Cite This Article

GÜNGÖR, S., PEKTAŞ, B., UZUN, B. K., DEMİRCİ, M., ER, H. (2022). Seropositivity of HBsAg, anti-HCV and anti-HIV in preoperative patients. Journal of Clinical and Experimental Investigations, Cilt: 4 - Sayı: 4, 449–452. https://ajindex.com/articles/561838

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Fry DE. Occupational risks of blood exposure in the operating room. Am Surgeon 2007;73:637-646
  2. Phillips EK, Owusu-Ofori A, Jagger J. Bloodborne pathogen exposure risk among surgeons in Sub- Saharan Africa. Infect Control Hosp Epidemiol 2007;28:1334-1336
  3. Hoşoglu S, Akalın S, Sünbül M, et al. Predictive factors for occupational bloodborne exposure in Turkish hospitals. Am J Infect Control 2009;37:65-69
  4. Öner M, Güney A, Halıcı M, et al. Ortopedik cerrahi uygulanan olgularda hepatit B ve Hepatit C prevalansı: 10 yıllık retrospektif çalışma. Genel Tıp Derg 2007;17:167-171
  5. Horvat RT, Tegtmeier GE. Hepatit B ve D virüsleri. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. (Başustaoğlu A, çeviri ed.) Klinik Mikrobiyoloji (Manuel of Clinical Microbiology). Ankara. Atlas Kitapçılık 2009;1601-1621
  6. Scott JD, Gretch DR. Hepatitis C ve G virüsleri. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. (Başustaoğlu A, çeviri ed.) Klinik Mikrobiyoloji (Manuel of Clinical Microbiology). Ankara. Atlas Kitapçılık 2009;1601-1621
  7. Dursun M, Ertem M, Yılmaz S, et al. Prevalence of hep- atitis B infection in the Southeastern Region of Turkey: Comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis 2005;58:15-19
  8. Mıstık R. Türkiye’de viral hepatit epidemiyolojisi yayınların irdelenmesi. Tabak F, Balık İ, Tekeli E, ed. Viral hepatit 2007. Viral hepatitle Savaşım Derneği, İstanbul, 1. baskı: 10-51
  9. Jagger J, De Carli G, Perry JL, et al. Occupational ex- posure to blood-borne pathogens: Epidemiology and prevention. In: Venzel RP, ed. Prevention and Control of Nosocomial Infection. 4th ed. Philadelphia: Lippin- cott Williams & Wilkins, 2003:431-461
  10. Kargı E, Külah C, Hoşnuter M, et al. Plastik cerrahide hepatit B, hepatit C ve HIV enfeksiyonu riski. Düzce Tıp Fak Derg 2003;5:14-17
  11. Caillot JL, Voiglio EJ. First clinical study of a new virus inhibiting surgical glove. Swiss Med Wkly 2008;138:18-22
  12. Masood Z, Jawaid M, Khan RA, Rehman S. Screen- ing for Hepatitis B and C: A routine preoperative investigation? Pak J Med Sci 2005;21:455-459
  13. Ahmad I, Khan SB, Rehman H, et al. Frequency of hepatitis B and Hepatitis C among cataract patients. Gomal J Med Science 2006;4:61-64
  14. Ganiczak M, Szych Z. Rationale for the implementa- tion of preoperative testing for HCV in the light of HCV and HBsAg tests results in surgical patients from a teaching hospital. Przegl Epidemiol 2009;63: